Roanna Ruiz – Leerink Partners

Leerink Partners

At Leerink Partners, this analyst has issued 9 tracked ratings across 9 distinct tickers, predominantly bullish with 8 bullish ratings and 1 hold, alongside a 1.5-star track record on the captured sample.

Aggregated from multiple market-data sources

Total ratings

Tickers covered

Sources

Aggregated

Latest rating

1 months ago

2026-04-28 00:00:00+00

Track record

Aggregated

No track record data

Bullish: 12
Hold: 3
Bearish: 0

Aggregated

60% success rate

Bullish: 0
Hold: 0
Bearish: 0

Aggregated

Not available

Bullish: 13
Hold: 1
Bearish: 0

Recent ratings

Ticker	Date	Rating	Price target	Source
CRMD	2026-04-28	buy	$14.00	Aggregated
UTHR	2026-03-02	buy	$615.00	Aggregated
CYTK	2026-02-26	buy	$84.00	Aggregated
MNKD	2026-02-25	buy	-	Aggregated
CYTK	2026-01-13	buy	-	Aggregated
TRVI	2025-11-18	buy	$16.00	Aggregated
IBIO	2025-10-17	buy	$2.00	Aggregated
ENTA	2025-10-01	hold	$9.00	Aggregated
AKBA	2025-08-22	buy	$7.00	Aggregated
LNTH	2025-08-22	buy	$99.00	Aggregated
XERS	2025-08-20	buy	$9.00	Aggregated
XERS	2025-08-19	buy	$9.00	Aggregated
XERSXERIS BIOPHARMA HOLDINGS INC	2025-08-19	unknown	$9.00	Aggregated
SPRY	2025-08-14	buy	$28.00	Aggregated
NAMS	2025-08-07	buy	$44.00	Aggregated
VIR	2025-08-06	buy	$16.00	Aggregated
ARDX	2025-08-05	buy	$11.00	Aggregated
AMRN	2025-07-31	hold	$10.00	Aggregated
AKBA	2025-04-28	buy	$7.00	Aggregated
AKBAAKEBIA THERAPEUTICS INC.	2025-04-28	unknown	$7.00	Aggregated
XERS	2025-03-07	buy	$6.00	Aggregated
LXRX	2025-03-04	hold	$1.00	Aggregated
LXRXLEXICON PHARMACEUTICALS INC	2025-03-04	unknown	$1.00	Aggregated
SPRY	2025-01-13	buy	$27.00	Aggregated
VIR	2025-01-13	buy	$20.00	Aggregated
AQST	2024-10-25	buy	$13.00	Aggregated
AQST	2024-09-30	buy	$12.00	Aggregated
SPRY	2024-09-20	buy	$25.00	Aggregated
SPRYARS PHARMACEUTICALS INC	2024-09-20	unknown	$25.00	Aggregated
AQST	2024-05-10	buy	$8.00	Aggregated
SPRY	2024-03-05	buy	$18.00	Aggregated

Tickers covered(21)

Ticker	Ratings	Last rating	Sources
CRMD	1	2026-04-28	Aggregated
UTHR	2	2026-03-02	Aggregated
CYTK	2	2026-02-26	Aggregated
MNKD	1	2026-02-25	Aggregated
TRVI	1	2025-11-18	Aggregated
IBIO	1	2025-10-17	Aggregated
ENTA	1	2025-10-01	Aggregated
AKBA	2	2025-08-22	Aggregated
LNTH	1	2025-08-22	Aggregated
XERS	3	2025-08-20	Aggregated
XERSXERIS BIOPHARMA HOLDINGS INC	1	2025-08-19	Aggregated
SPRY	4	2025-08-14	Aggregated
NAMS	1	2025-08-07	Aggregated
VIR	2	2025-08-06	Aggregated
ARDX	1	2025-08-05	Aggregated
AMRN	2	2025-07-31	Aggregated
AKBAAKEBIA THERAPEUTICS INC.	1	2025-04-28	Aggregated
LXRX	1	2025-03-04	Aggregated
LXRXLEXICON PHARMACEUTICALS INC	1	2025-03-04	Aggregated
AQST	3	2024-10-25	Aggregated
SPRYARS PHARMACEUTICALS INC	1	2024-09-20	Aggregated

Methodology differs by source. Track records are aggregated from multiple sources; scoring methodology and scales differ by source and values are not directly comparable. Coverage is sourced from publicly-aggregated analyst activity. Past performance does not guarantee future results. Not investment advice.